
Results
8
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
8 companies
Roche Holding
Market Cap: CHF 256.1b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROG
CHF 320.70
7D
-6.0%
1Y
4.9%
Novartis
Market Cap: CHF 231.6b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 121.36
7D
-1.5%
1Y
26.0%
Kuehne + Nagel International
Market Cap: CHF 20.3b
Provides integrated logistics services in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
KNIN
CHF 171.35
7D
-0.9%
1Y
-18.6%
Geberit
Market Cap: CHF 18.3b
Develops, produces, and distributes sanitary products and systems for the residential and commercial construction industry.
GEBN
CHF 555.60
7D
-3.0%
1Y
-4.9%
Logitech International
Market Cap: CHF 10.8b
Through its subsidiaries, designs, manufactures, and markets software-enabled hardware solutions that connect people to working, creating, and gaming worldwide.
LOGN
CHF 73.40
7D
4.7%
1Y
-7.5%
Burckhardt Compression Holding
Market Cap: CHF 1.8b
Manufactures and sells reciprocating compressor technologies worldwide.
BCHN
CHF 521.00
7D
-5.3%
1Y
-16.0%
Basilea Pharmaceutica
Market Cap: CHF 636.7m
A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.
BSLN
CHF 51.80
7D
-0.4%
1Y
9.4%
APG|SGA
Market Cap: CHF 623.4m
Provides advertising services primarily in Switzerland and Serbia.
APGN
CHF 208.00
7D
-0.5%
1Y
-8.0%